Association of vitamin D status and the risk of cardiovascular disease as assessed by various cardiovascular risk scoring systems in patients with type 2 diabetes mellitus

References

• Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res. 2014;7:69–87.
   PubMedGoogle Scholar
• Piantanida E, Gallo D, Veronesi G, et al. Cardiometabolic healthy and unhealthy obesity: does vitamin D play a role? Endocr Connect. 2017;6:943–951.
   PubMed Web of Science ®Google Scholar
• Arababadi MK, Nosratabadi R, Asadikaram G. Vitamin D and toll like receptors. Life Sci. 2018;203:105–111.
   PubMed Web of Science ®Google Scholar
• Li YC, Qiao G, Uskokovic M, et al. Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004;89–90:387–392.
   PubMed Web of Science ®Google Scholar
• Leung PS. The potential protective action of vitamin D in hepatic insulin resistance and pancreatic islet dysfunction in type 2 diabetes mellitus. Nutrients. 2016;8:147.
   PubMed Web of Science ®Google Scholar
• Mitri J, Pittas AG. Vitamin D and diabetes. Endocrinol Metab Clin North Am. 2014;43:205–232.
   PubMed Web of Science ®Google Scholar
• Kendrick J, Targher G, Smits G, et al. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2009;205:255.
   PubMed Web of Science ®Google Scholar
• Dziedzic EA, Gąsior JS, Pawłowski M, et al. Association of vitamin D deficiency and degree of coronary artery disease in cardiac patients with type 2 diabetes. J Diabetes Res. 2017;2017:3929075..
   PubMedGoogle Scholar
• Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP‐1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM. 2002;95:787–796.
   PubMed Web of Science ®Google Scholar
• Basat S, Sivritepe R, Ortaboz D, et al. The relationship between vitamin D level and erectile dysfunction in patients with type 2 diabetes mellitus. Aging Male. 2018;21:111–115.
   PubMed Web of Science ®Google Scholar
• Park SG, Yeo JK, Cho DY, et al. Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms/benign prostatic hyperplasia. Aging Male. 2018;21:55–59.
   PubMed Web of Science ®Google Scholar
• Canguven O, Talib RA, El Ansari W, et al. Vitamin D treatment improves levels of sexual hormones, metabolic parameters and erectile function in middle-aged vitamin D deficient men. Aging Male. 2017;20:9–16.
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Padovani R, et al. Serum 25‐hydroxyvitamin D3 concentrations and carotid artery intima‐media thickness among type 2 diabetic patients. Clin Endocrinol. 2006;65:593–597.
   PubMed Web of Science ®Google Scholar
• Joergensen C, Gall M-A, Schmedes A, et al. Vitamin D levels and mortality in type 2 diabetes. Diabetes Care. 2010;33:2238–2243.
   PubMed Web of Science ®Google Scholar
• Cremer A, Tambosco C, Corcuff JB, et al. Investigating the association of vitamin D with blood pressure and the renin–angiotensin–aldosterone system in hypertensive subjects: a cross-sectional prospective study. J Hum Hypertens. 2018;32:114–121.
   PubMed Web of Science ®Google Scholar
• Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med. 2010;88:441–450.
   PubMed Web of Science ®Google Scholar
• Kyaw T, Winship A, Tay C, et al. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in ApoE-/-mice. Circulation AHA. 2013;127:1028–1039.
   PubMed Web of Science ®Google Scholar
• McMullan CJ, Borgi L, Curhan GC, et al. The effect of vitamin D on renin–angiotensin system activation and blood pressure: a randomized control trial. J Hypertens. 2017;35:822–829.
   PubMed Web of Science ®Google Scholar
• The Society of Endocrinology and Metabolism of Turkey. Osteoporosis and metabolic bone diseases diagnosis and treatment manual. Yenimahalle/Ankara: Miki Matbaacılık San. and Tic. Ltd. Sti; 2017. p. 119–127.
   Google Scholar
• Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008;336:1475–1482.
   PubMed Web of Science ®Google Scholar
• Edinburgh (CVD and CHD), BNF, ASSIGN, Stroke, CHD Death, CVD Death Payne R. Cardiovascular Risk Calculators [Internet]. Edinburgh, UK: University of Edinburgh; 2005 [cited 2014 Jan 15]. Available from: http://cvrisk.mvm.ed.ac.uk/calculator/calc.asp.
   Google Scholar
• Conroy R, Pyörälä K, Fitzgerald AE, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003.
   PubMed Web of Science ®Google Scholar
• Framingham Heart Study. Risk score profiles. Available from: http://www.framinghamheartstudy.org/risk
   Google Scholar
• Gutiérrez-Robledo LM, Ávila-Funes JA, Amieva H, et al. Association of low serum 25-hydroxyvitamin D levels with the frailty syndrome in Mexican community-dwelling elderly. Aging Male. 2016;19:58–63.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503–511.
   PubMed Web of Science ®Google Scholar
• Scragg R, Khaw KT, Murphy S. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr. 1995;49:640–646.
   PubMed Web of Science ®Google Scholar
• Norman PE, Powell JT. Vitamin D and cardiovascular disease. Circ Res. 2014;114:379–393.
   PubMed Web of Science ®Google Scholar
• Cheng JB, Levine MA, Bell NH, et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci. 2004;101:7711–7715.
   PubMed Web of Science ®Google Scholar
• Cigolini M, Iagulli MP, Miconi V, et al. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2006;29:722–724.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Kotake M, Ono Y, et al. Hypovitaminosis D in type 2 diabetes mellitus: association with microvascular complications and type of treatment. Endocr J. 2006; 53:503–510.
   PubMed Web of Science ®Google Scholar
• Di Cesar DJ, Ploutz-Snyder R, Weinstock RS, et al. Vitamin D deficiency is more common in type 2 than in type 1 diabetes. Diabetes Care. 2006; 29:174.
   PubMed Web of Science ®Google Scholar
• Tahrani AA, Ball A, Shepherd L, et al. The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK. Int J Clin Pract. 2010; 64:351–355.
   PubMed Web of Science ®Google Scholar
• Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care. 2001;24:1496. http://care.diabetesjournals.org/content/diacare/24/8/1496.1.full.pdf
   PubMed Web of Science ®Google Scholar
• Satman I, Ozbey NC, Boztepe H, et al. Prevalence and of vitamin D deficiency and associated factors in Turkey. Diabetes. 2012;190:6–9.
   Google Scholar
• Adorini L, Penna G. Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists. Hum Immunol. 2009;70:345–352.
   PubMed Web of Science ®Google Scholar
• Garbossa SG, Folli F. Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism. Rev Endocr Metab Disord 2017;18:243–258.
   PubMed Web of Science ®Google Scholar
• Yu JR, Lee SA, Lee J-G, et al. Serum vitamin D status and its relationship to metabolic parameters in patients with type 2 diabetes mellitus. Chonnam Med J. 2012;48:108–115.
   PubMedGoogle Scholar
• Witham MD, Dove FJ, Dryburgh M, et al. The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2010;53:2112–2119.
   PubMed Web of Science ®Google Scholar
• Nonn L, Peng L, Feldman D, et al. Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D. Cancer Res. 2006;66:4516–4524.
   PubMed Web of Science ®Google Scholar
• Culha MG, Atalay HA, Canat HL, et al. The relationship between erectile dysfunction severity, mean platelet volume and vitamin D levels. Aging Male. 2018;1–6. DOI:10.1080/13685538.2018.1459544
   PubMedGoogle Scholar
• Vanlint S. Vitamin D and Obesity. Nutrients. 2013;5:949–956.
   PubMed Web of Science ®Google Scholar
• Rosina KT, Barreto APMM, Pontes KS, et al. Vitamin D status in renal transplant recipients living in a low-latitude city: association with body fat, cardiovascular risk factors, estimated glomerular filtration rate and proteinuria. Br J Nutr. 2017;117:1279–1290.
   PubMed Web of Science ®Google Scholar
• Park K, Elias PM, Oda Y, et al. Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway. J Biol Chem. 2011;286:34121–34130.
   PubMed Web of Science ®Google Scholar
• Kumaratne M, Early G, Cisneros J. Vitamin D deficiency and association with body mass index and lipid levels in Hispanic American adolescents. Glob Pediatr Health. 2017;4:2333794X1774414.
   Google Scholar
• World Health Organization. Global status report on road safety 2015. Geneva: World Health Organization; 2015.
   Google Scholar